Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Treatment Patterns, BRCA Testing Practices, Outcomes, and Health Care Utilization in Platinum-Sensitive Recurrent Serous Ovarian Cancer: A Multi-Country Retrospective Study

NCT02262273 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02262273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02262273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Treatment Patterns, BRCA Testing Practices, Outcomes, and Health Care Utilization in Platinum-Sensitive Recurrent Serous Ovarian Cancer: A Multi-Country Retrospective Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
April 30, 2016
Enrollment
2,123 (actual)
Sites
199

Conditions

As the registry lists them; a condition with its own page is linked.

platinum-sensitive recurrent serous ovarian cancer